Skip to main content
ROVI Subsidiaries
Spain
Germany
France
Italy
Poland
Portugal
United Kingdom
Language
Spanish
Spanish
English
English
English
Español
Home
ROVI
History
Group structure
Business units
International expansion
Strategy
Licenses
Contact
Products
Prescription Pharmaceuticals
Hospital Products
Manufacturing
CDMO
Own product Manufacturing
R&D
Shareholders and Investors
The share
Investor's Calendar
News
Financial and Business Information
CMNV Communications
ESG
Corporate Governance
Telematic assistance access
Prior Registration On-Line Attendance
On-Line Attendance
Sustainability
Responsible governance
Commitment to people
Environmental Commitment
Ethics Channel
Media
FAQS
News
ROVI up to date
Contact
Work with Us
TELEMATIC ASSISTANCE ACCESS
Home
>
Shareholders and investors
> Public Statements Sent to CNMV
Public Statements Sent to CNMV
Find out more about ...
The Share
Investor's Calendar
News
Financial and Business Information
Public Statements Sent to CNMV
ESG
Corporate Governance
Inside Information
Year
-Year
2020
2021
2022
2023
2024
Date
Title
Description
PDF
09 Jul 2020
On business and financial situation
ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate
Download
Pages
«
‹
…
4
5
6
7
8
9
Other Relevant Information
Year
-Year
2020
2021
2022
2023
2024
Date
Title
Description
PDF
26 Feb 2020
Annual Corporate Governance Report
ROVI releases the 2019 Annual Corporate Governance Report
Download
Pages
«
‹
…
26
27
28
29
30
31
Relevant events prior to February 8, 2020 Year
Year
-Year
2015
2016
2017
2018
2019
2020
Date
Title
Description
PDF
07 Nov 2013
Información sobre resultados (2)
Download
06 Nov 2013
Información sobre resultados
Download
31 Jul 2013
Información sobre resultados
Download
31 Jul 2013
Información sobre resultados (2)
Download
01 Jul 2013
Información sobre dividendos
Download
Pages
«
‹
…
30
31
32
33
34
35
…
›
»
